Restricted access to assisted reproductive technology and fertility preservation: legal and ethical issues

Abstract

We review the legal and ethical framework of reproductive medicine in Brazil and discuss whether and why reproductive health is a basic right of citizens. Since infertility is a true disease, its treatment should be affordable in any health system that claims to be universal.

Evaluation of the Risk of Birth Defects Related to the Use of Assisted Reproductive Technology: An Updated Systematic Review

“…One such possibility involves the use of ART in a situation where the current conventional and/or surgical treatment has not achieved the expected results [3,6]. Nevertheless, ART continues to be an ethical conundrum, especially in conservative societies, in addition to the fear of ART-induced birth defects [49][50][51]. In Poland, the first IVF treatment took place in 1987 at the Institute of Obstetrics and Women's Diseases at the Medical Academy in Białystok, headed by Prof. Marian Szamatowicz [52].…”

Ethical issues surrounding the use of assisted reproductive technologies in Ghana: An analysis of the experiences of clients and service providers

“…Due to their great cost, only the wealthy can afford ARTs, raising ethical issues. Oliviera et al [ 12 ] also conducted a study that was quite similar to this one, and it examined the current state of ART and fertility preservation in Brazil. According to the results of their study, access to ART and fertility preservation therapies in Brazil is neither simple nor equitable.…”

Supplementation with NAD+ and its precursors: A rescue of female reproductive diseases

“…In addition, reproductive endocrine disorders such as polycystic ovary syndrome (PCOS) and tumors of the reproductive system also pose a massive damage to women's fertility. Currently, hormone replacement therapy (HRT) and assisted reproductive technology (ART) are mainly used to improve the pregnancy rate of women, but both have limitations [ 2 , 3 ]. Therefore, the search for new therapeutic breakthroughs to preserve fertility in women of reproductive age is the focus and difficulty of current research.…”